#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer Palmar-plantar erythrodysaesthesia syndrome Retinitis pigmentosa Still's disease Heavy menstrual bleeding IgA nephropathy Neonatal asphyxia Obliterative bronchiolitis Sjogren's syndrome Endometrial cancer recurrent Marginal zone lymphoma Asthma Anaplastic large cell lymphoma T- and null-cell types Haemophilia A with anti factor VIII Short stature More trials…

    Learn about Rare Diseases

    Behcet’s syndrome – Trials in Disease Alveolar rhabdomyosarcoma – Treatment Rosai-Dorfman syndrome – Treatment Gastrointestinal stromal tumour – Treatment Rhabdoid tumour – Life with Disease Immunodeficiency congenital – Basic Information Lennox-Gastaut syndrome – Trials in Disease Pleomorphic leiomyosarcoma – Treatment Mantle cell lymphoma stage II – Trials in Disease Pulmonary fibrosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bromhexine Hydrochloride Rizolipase TAZAROTENE Adrenaline Tartrate Ph. Eur. Mk-4830 Tak-280 Guanfacine Sodium Iotalamate (125I) Interferon Alfa Vafidemstat Alogliptin Fidanacogene Elaparvovec SP16 HYPOCHLOROUS ACID AVTX-009 Minoxidil Nnc0194-0499 Paltusotine 204-NETU TRIGLYCERIDES MEDIUM CHAIN More therapies…

    Learn about Your Condition

    Cutaneous lupus erythematosus Pulmonary congestion Myasthenia gravis Ependymoma Obsessive-compulsive disorder Wheezing Iron deficiency anaemia Hepatitis D Myotonic dystrophy Migraine without aura Cytomegalovirus infection Gastrectomy Chronic sinusitis Noonan syndrome Craniosynostosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the effect of sodium oxybate on sleep quality in adult patients in intensive care units

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Sleep disorder
    Investigated Drugs:
    • Sodium Oxybate
    France

  • A study to evaluate the effectiveness and safety of AP707 in patients with borderline personality disorder.

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Borderline personality disorder
    Investigated Drugs:
    • Adezunap
    Germany

  • A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Austria Belgium Czechia Denmark France Germany +9

  • Comparison of ceftriaxone and azithromycin versus amoxicillin and azithromycin for pregnant women with preterm premature rupture of membranes between 22 and 33 weeks.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Abortion threatened
    Investigated Drugs:
    • Azithromycin
    • Ceftriaxone
    • Amoxicillin
    France

  • Study to evaluate the effect of methylphenidate hydrochloride on the time to wake up in patients in a coma due to acute brain injury

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Coma
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    Austria Denmark France Germany

  • A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    Belgium Bulgaria Czechia France Germany Poland +2
Previous Page
1 … 716 717 718 719 720 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!